Vor Biopharma Inc. (NYSE:VOR) Expected to Earn Q2 2022 Earnings of ($0.72) Per Share

Retrieved on: 2022-07-30 06:02:02

Tags for this article:

Click the tags to see associated articles and topics

Vor Biopharma Inc. (NYSE:VOR) Expected to Earn Q2 2022 Earnings of ($0.72) Per Share. View article details on hiswai:

Excerpt

Wedbush currently has a “Initiates” rating on the stock. The consensus estimate for Vor Biopharma's current full-year earnings is ($2.73) per share.

Article found on: reporter.am